Clinical trial · Interventional
Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project will assess the efficacy of an 8-week virtual exercise program on physical function offered to those with a breast cancer diagnosis currently receiving endocrine therapy. The intervention includes twice-weekly virtual group exercise classes. Participants also complete one to three independent home exercise sessions per week throughout the intervention. Testing will occur virtually at baseline, 8-weeks (at end of program) and follow-up evaluations will be performed at 16-weeks and 12- months after baseline testing. Questionnaires will be administered through REDCap. Exercise sessions and testing will be administered virtually via Zoom.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Delayed Intervention Group | Behavioral | — | UNRESOLVED |
| Immediate Intervention Group | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Immediate Intervention Group
- description
- The intervention is an 8-week combined aerobic and resistance program, with virtual, group-based, supervised exercise sessions twice per week (60 min). The intervention also includes optional education on healthy eating.
- interventionNames
- Behavioral: Immediate Intervention Group
- type
- EXPERIMENTAL
- label
- Delayed Intervention Group
- description
- Usual lifestyle control for 8 weeks and then invited to participate in the exercise intervention.
- interventionNames
- Behavioral: Delayed Intervention Group
Primary outcomes (1)
- measure
- Physical Function
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 19 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Stage I - III breast cancer patients who are treated with curative intent * Completed primary treatment, including surgery, radiation therapy and/or chemotherapy * Currently receiving adjuvant endocrine therapy (Tamoxifen or an Aromatase Inhibitor) for at least 3 months (to allow for acclimatization) and within 3-years of of staring endocrine therapy. * Can read and speak English * Has access to a tablet, smartphone, laptop or computer with built-in video camera Exclusion Criteria: * Not currently receiving endocrine therapy or scheduled to stop within 6 months * Diagnosed with stage IV breast cancer * Not willing to attend a twice-weekly exercise program virtually for the duration of the study. * Not willing to comply with safety measures of virtual programming (to be seen on camera and monitored via video by the instructor)
References
Publications (0)
Data not yet available